Review: Systemic consequences of COPD
Authors:
- 1 October 2007
- journal article
- review article
- Published by SAGE Publications in Therapeutic Advances in Respiratory Disease
- Vol. 1 (1) , 47-59
Abstract
Chronic obstructive pulmonary disease (COPD) is a highly prevalent chronic lung condition, affecting ∼10% of adults over the age of 40 years in the western world. Research over the past 10 years has shown that COPD is more than just a lung disorder; it affects other end-organs including the cardiovascular and the musculoskeletal systems, making it a multi-component, multi-system disease. COPD increases the risk for ischemic heart disease, stroke, osteoporosis, cachexia, and muscle weakness by two to threefold, independent of other factors such as smoking and age. The mechanisms by which COPD affects these end-organs, however, are unclear. In this paper, we review some of the common and serious extra-pulmonary manifestations of COPD and the potential mechanisms by which they can be linked with COPD.Keywords
This publication has 78 references indexed in Scilit:
- Systemic Effects of Chronic Obstructive Pulmonary DiseaseProceedings of the American Thoracic Society, 2005
- Cancer cachexia is regulated by selective targeting of skeletal muscle gene productsJournal of Clinical Investigation, 2004
- Cognitive impairment in chronic obstructive pulmonary diseaseJournal of Neurology, 2003
- Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary diseaseIntensive Care Medicine, 2003
- Skeletal Muscle Apoptosis and Weight Loss in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Elevated Plasma Procoagulant and Fibrinolytic Markers in Patients with Chronic Obstructive Pulmonary Disease.Internal Medicine, 2002
- Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 1997
- Effect of Supplementary Antioxidant Vitamin Intake on Carotid Arterial Wall Intima-Media Thickness in a Controlled Clinical Trial of Cholesterol LoweringCirculation, 1996
- Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1JAMA, 1994
- Effects of pulmonary function on mortalityJournal of Chronic Diseases, 1985